Biomarkers of lung cancer risk and progression
Lung cancer causes high mortality because most people present late with advanced disease that is not amenable to curative treatment. Screening high-risk groups with low dose CT imaging of the thorax has been shown to reduce lung cancer mortality by 20%, but at the cost of a high false positive rate....
| Main Author: | |
|---|---|
| Other Authors: | |
| Published: |
University of Sheffield
2019
|
| Subjects: | |
| Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.766577 |